These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 16867045

  • 41. Clinical predictors of duration of action of cisatracurium and rocuronium administered long-term.
    Fassbender P, Geldner G, Blobner M, Hofmockel R, Rex C, Gautam S, Malhotra A, Eikermann M.
    Am J Crit Care; 2009 Sep; 18(5):439-45. PubMed ID: 19723864
    [Abstract] [Full Text] [Related]

  • 42. Intraoperative anaphylaxis to neuromuscular blocking agents: the incidence over 9 years at two tertiary hospitals in South Korea: A retrospective observational study.
    Cho YJ, Ju JW, Sim H, Lee JH, Hong DM, Kim TK, Min JJ, Song WJ, Kang HR, Cho SH, Jeon Y.
    Eur J Anaesthesiol; 2016 May; 33(5):368-78. PubMed ID: 26575006
    [Abstract] [Full Text] [Related]

  • 43. Basophil activation can predict clinical sensitivity in patients after venom immunotherapy.
    Kucera P, Cvackova M, Hulikova K, Juzova O, Pachl J.
    J Investig Allergol Clin Immunol; 2010 May; 20(2):110-6. PubMed ID: 20461965
    [Abstract] [Full Text] [Related]

  • 44. Case report: treatment of rocuronium-induced anaphylactic shock with vasopressin.
    Meng L, Williams EL.
    Can J Anaesth; 2008 Jul; 55(7):437-40. PubMed ID: 18591701
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Diagnosis of neuromuscular blocking agent hypersensitivity reactions using cytofluorimetric analysis of basophils.
    Kvedariene V, Kamey S, Ryckwaert Y, Rongier M, Bousquet J, Demoly P, Arnoux B.
    Allergy; 2006 Mar; 61(3):311-5. PubMed ID: 16436139
    [Abstract] [Full Text] [Related]

  • 50. [Severe anaphylaxis associated with rocuronium administration].
    Bermejo Alvarez MA, Carpintero M, Cosío F, Fervienza P, Castañón E.
    Rev Esp Anestesiol Reanim; 2004 Nov; 51(9):562-3. PubMed ID: 15620172
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Successful management of rocuronium-induced anaphylaxis with sugammadex: A case report.
    Hung SK, Yeh CC, Ting PC, Chen CH, Kao MC.
    J Int Med Res; 2022 Jul; 50(7):3000605221113913. PubMed ID: 35869623
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones.
    Elst J, Maurer M, Sabato V, Faber MA, Bridts CH, Mertens C, Van Houdt M, Van Gasse AL, van der Poorten MM, De Puysseleyr LP, Hagendorens MM, Van Tendeloo VF, Lion E, Campillo-Davo D, Ebo DG.
    Front Immunol; 2021 Jul; 12():668962. PubMed ID: 34385999
    [Abstract] [Full Text] [Related]

  • 55. Influence of gender on the course of neuromuscular block following a single bolus dose of cisatracurium or rocuronium.
    Adamus M, Gabrhelik T, Marek O.
    Eur J Anaesthesiol; 2008 Jul; 25(7):589-95. PubMed ID: 18405411
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Severe intraoperative anaphylactic reaction: aprotinin and rocuronium.
    Santos Silva F.
    J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):740-3. PubMed ID: 18922434
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.